Pediatric psychotropic medication initiation and adherence: a literature review based on social exchange theory.

TOPIC Psychotropic medication initiation and adherence is an identified problem. This literature review explores factors that determine families' decisions to initiate, sustain, or discontinue use of psychotropic medication in children and adolescents. Social exchange theory is used as a framework to explore decisions to initiate and adhere to psychotropic medications. PURPOSE Contributing factors related to psychotropic medication initiation, adherence, and discontinuation are explored. Themes in the literature encompassing costs and benefits of psychotropic medication adherence include family experiences with adverse effects, previous psychotropic medication experience, medication psychoeducation, stigma, societal views about psychotropic medication, particular diagnosis, the effect of comorbid diagnosis on adherence, attitudes and beliefs about medication by both children and parents, and relationships with the provider. The impact of family demographics including parent gender, age of the child, ethnicity, and parent educational level on psychotropic medication adherence is evaluated. SOURCES International and U.S. studies from Medline, Cumulative Index for Nursing and Allied Health Literature and PsychInfo evaluating medication initiation and adherence in the pediatric psychiatric population and social exchange theory was incorporated from relevant textbook resources. CONCLUSIONS Rewards experienced from medication treatment include improvement in symptoms, school performance and family relationships, and reduced level of parenting stress. Identified costs include impact of adverse side effects, social stigma, lack of response, fears of addiction, and changing the child's personality. Acceptance of the diagnosis influences adherence while medication education has varying effects. Families' attitudes, beliefs and perceptions about psychiatric illness and treatment play a large role in medication treatment decisions. A trusting provider relationship has a positive effect on adherence. Psychosocial treatment alternatives are preferred. With maturation, adolescents have more influence on decisions related to adherence.

[1]  A. Koivisto,et al.  Depression and school performance in middle adolescent boys and girls. , 2008, Journal of adolescence.

[2]  Mirka Koro-Ljungberg,et al.  Analysis of Critical Incidents and Shifting Perspectives: Transitions in Illness Careers Among Adolescents With ADHD , 2009, Qualitative health research.

[3]  E. Hansen,et al.  Caught in a Balancing Act: Parents’ Dilemmas Regarding Their ADHD Child’s Treatment With Stimulant Medication , 2006, Qualitative health research.

[4]  J. Lönnqvist,et al.  [Depression and suicide]. , 1994, Duodecim; laaketieteellinen aikakauskirja.

[5]  Asha K. Jitendra,et al.  Elementary school students with AD/HD: predictors of academic achievement , 2004 .

[6]  C. Johnston,et al.  Childrearing Discussions in Families of Nonproblem Children and ADHD Children With Higher and Lower Levels of Aggresive-Defiant Behavior , 1993 .

[7]  B. Pescosolido,et al.  Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness. , 2007, Psychiatric services.

[8]  V. Barone,et al.  Mothers' and Children's Perceptions of Medication for Children with Attention-Deficit Hyperactivity Disorder , 2000, Child psychiatry and human development.

[9]  G. Salmon,et al.  Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.

[10]  J. Biederman.  Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. , 2003, The Journal of clinical psychiatry.

[11]  R. Sabatelli,et al.  Exchange and Resource Theories , 2009 .

[12]  T. Cheng,et al.  Community perspectives of childhood behavioral problems and ADHD among African American parents. , 2007, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[13]  María C. Fernández,et al.  Latina Mothers' Stances on Stimulant Medication: Complexity, Conflict, and Compromise , 2004, Journal of developmental and behavioral pediatrics : JDBP.

[14]  Murray B Stein,et al.  Parental Opinions Regarding Treatment for Social Anxiety Disorder in Youth , 2003, Journal of developmental and behavioral pediatrics : JDBP.

[15]  D. Klein,et al.  SCHOOL PHOBIA: DIAGNOSTIC CONSIDERATIONS IN THE LIGHT OF IMIPRAMINE EFFECTS , 1973, The Journal of nervous and mental disease.

[16]  M. King,et al.  Stimulant medication in ADHD: what do children and their parents say? , 2005, Irish Journal of Psychological Medicine.

[17]  Maryellen C Pachler,et al.  Pediatric bipolar disorder: evidence-based psychopharmacological treatments. , 2007, Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc.

[18]  N. Garnefski.  Age differences in depressive symptoms, antisocial behavior, and negative perceptions of family, school, and peers among adolescents. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[19]  F. Gary,et al.  Parental explanatory models of ADHD , 2003 .

[20]  Peter V. Marsden,et al.  Introducing Influence Processes into a System of Collective Decisions , 1981, American Journal of Sociology.

[21]  L. Epstein,et al.  The effects of targeting improvements in urine glucose on metabolic control in children with insulin dependent diabetes. , 1981, Journal of applied behavior analysis.

[22]  L. Derogatis,et al.  Symptom Checklist‐90‐Revised , 2010 .

[23]  A. Ghanizadeh.  Educating and counseling of parents of children with attention-deficit hyperactivity disorder. , 2007, Patient education and counseling.

[24]  J. Swanson.  Compliance with Stimulants for Attention-Deficit/Hyperactivity Disorder , 2003, CNS drugs.

[25]  M. Angermeyer,et al.  SUBJECTIVE ILLNESS THEORY AND ANTIPSYCHOTIC MEDICATION COMPLIANCE BY PATIENTS WITH SCHIZOPHRENIA , 2002, The Journal of nervous and mental disease.

[26]  D. Efron,et al.  Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder , 1998, Journal of paediatrics and child health.

[27]  A. Altamura,et al.  May duration of untreated illness influence the long-term course of major depressive disorder? , 2008, European Psychiatry.

[28]  L. Bastiaens.  Compliance with Pharmacotherapy in Adolescents: Effects of Patients' and Parents' Knowledge and Attitudes toward Treatment , 1995 .

[29]  R. Barkley,et al.  The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology. , 1991, Journal of child psychology and psychiatry, and allied disciplines.

[30]  Ronald T. Brown,et al.  Predictors of Stress in Caregivers of Attention-Deficit/Hyperactivity Disordered Children , 1995 .

[31]  B. Pescosolido,et al.  Public Attitudes toward the Use of Psychiatric Medications for Children∗ , 2004, Journal of health and social behavior.

[32]  Ilina Singh,et al.  Boys Will Be Boys: Fathers' Perspectives on ADHD Symptoms, Diagnosis, and Drug Treatment , 2003, Harvard review of psychiatry.

[33]  Robert D Gibbons,et al.  3-year follow-up of the NIMH MTA study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[34]  R. Barkley,et al.  The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  R. Gearing,et al.  Medication adherence for children and adolescents with first-episode psychosis following hospitalization , 2009, European Child & Adolescent Psychiatry.

[36]  L Eugene Arnold,et al.  What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? , 2005, Journal of consulting and clinical psychology.

[37]  M. Weissman,et al.  National trends in the use of psychotropic medications by children. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[38]  R. Sabatelli.  Marital Commitment and Family Life Transitions , 1999 .

[39]  D. Bennett,et al.  Parent acceptability and feasibility of ADHD interventions: assessment, correlates, and predictive validity. , 1996, Journal of pediatric psychology.

[40]  P. Blau.  Exchange and Power in Social Life , 1964 .

[41]  Y. Nevo,et al.  Attitudes Toward Attention-Deficit Hyperactivity Disorder (ADHD) Treatment: Parents' and Children's Perspectives , 2008, Journal of child neurology.

[42]  S. Hinshaw,et al.  Aggressive, prosocial, and nonsocial behavior in hyperactive boys: dose effects of methylphenidate in naturalistic settings. , 1989, Journal of consulting and clinical psychology.

[43]  P. Firestone.  Factors associated with children's adherence to stimulant medication. , 1982, The American journal of orthopsychiatry.

[44]  D. Cox,et al.  Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. , 2004, The Journal of the American Board of Family Practice.

[45]  K Rickels,et al.  Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. , 2001, The American journal of psychiatry.

[46]  Gerard Delanty.  The Foundations of Social Theory , 2009 .

[47]  Marley W. Watkins,et al.  ADHD and Achievement , 2007, Journal of learning disabilities.

[48]  G. C. Homans,et al.  Social Behavior: Its Elementary Forms. , 1975 .

[49]  R. McMahon,et al.  Factors mediating children's health care attitudes. , 1991, Journal of pediatric psychology.

[50]  H. Kraemer,et al.  Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder , 2005, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[51]  F. Gary,et al.  Parental explanatory models of ADHD: gender and cultural variations. , 2003 .

[52]  R. Sabatelli.  The Social Psychology of Groups , 2000 .

[53]  G. Norquist,et al.  Recent trends in stimulant medication use among U.S. children. , 2006, The American journal of psychiatry.

[54]  S. Simonian,et al.  Acceptability of Interventions for Childhood Depression , 1992, Behavior modification.

[55]  J. Brook,et al.  The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study. , 2008, The American journal on addictions.

[56]  E. Goodman,et al.  Trends in the use of psychotropic medications among adolescents, 1994 to 2001. , 2006, Psychiatric services.

[57]  Vanya Hamrin,et al.  Child & adolescent depression: review of the latest evidence-based treatments. , 2005, Journal of psychosocial nursing and mental health services.

[58]  S. Whiteside,et al.  Parents' perceptions of pharmacological and cognitive-behavioral treatments for childhood anxiety disorders. , 2007, Behaviour research and therapy.

[59]  C. Lévi-Strauss.  The Elementary Structures of Kinship , 1969 .

[60]  H. Kraemer,et al.  Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. , 2003, Journal of consulting and clinical psychology.

[61]  Michael J Wade,et al.  Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York. , 2005, Journal of child and adolescent psychopharmacology.

[62]  K. Soeken,et al.  Parental Perceptions and Satisfaction with Stimulant Medication for Attention‐Deficit Hyperactivity Disorder , 2003, Journal of developmental and behavioral pediatrics : JDBP.

[63]  Cheng-Sheng Chen,et al.  Rapid improvement in academic grades following methylphenidate treatment in attention‐deficit hyperactivity disorder , 2004, Psychiatry and clinical neurosciences.

[64]  E Isaacs,et al.  Fluvoxamine for the treatment of anxiety disorders in children and adolescents. , 2001, The New England journal of medicine.

[65]  S. Strakowski,et al.  Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder. , 2005, Journal of child and adolescent psychopharmacology.

[66]  J. Nigg,et al.  Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years? , 2009, Clinical psychology review.

[67]  J. Goll,et al.  Associated features of Asperger Syndrome and their relationship to parenting stress. , 2008, Child: care, health and development.

[68]  O. Bukstein.  Satisfaction with treatment for attention-deficit/hyperactivity disorder. , 2004, The American journal of managed care.

[69]  E. K. Sleator,et al.  How do Hyperactive Children Feel About Taking Stimulants and Will They Tell the Doctor? , 1982, Clinical pediatrics.

[70]  M. Keller,et al.  Improving the course of illness and promoting continuation of treatment of bipolar disorder. , 2004, The Journal of clinical psychiatry.

[71]  David Daley,et al.  The attention-deficit/hyperactivity disorder medication-related attitudes of patients and their parents. , 2008, Journal of child and adolescent psychopharmacology.

[72]  Benedetto Vitiello,et al.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. , 2004, JAMA.

[73]  B. Pescosolido,et al.  AMERICAN ATTITUDES TOWARD AND WILLINGNESS TO USE PSYCHIATRIC MEDICATIONS , 2003, The Journal of nervous and mental disease.

[74]  B. Birmaher,et al.  Treatment guidelines for children and adolescents with bipolar disorder. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[75]  R. Findling,et al.  Adolescent attitudes toward psychiatric medication: the utility of the Drug Attitude Inventory. , 2009, Journal of child psychology and psychiatry, and allied disciplines.

[76]  J. Waddington,et al.  Untreated illness and outcome of psychosis , 2006, British Journal of Psychiatry.

[77]  C. Johnston,et al.  Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics. , 2008, Behavior therapy.

[78]  H. Lazaratou,et al.  Parental attitudes and opinions on the use of psychotropic medication in mental disorders of childhood , 2007, Annals of general psychiatry.

[79]  M. Crismon,et al.  Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[80]  R. Post,et al.  Parental attitudes towards early intervention in children at high risk for affective disorders. , 2002, Journal of affective disorders.

[81]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[82]  K. Cook,et al.  Social Exchange Theory , 1989, Theoretical Sociology.

[83]  P. Jensen,et al.  Psychosocial and medical histories of stimulant-treated children. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[84]  S. Strakowski,et al.  Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. , 2007, The American journal of psychiatry.

[85]  B. Birmaher,et al.  Fluoxetine for the treatment of childhood anxiety disorders. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[86]  Philip D. Harvey,et al.  Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients. , 2005, Journal of child and adolescent psychopharmacology.

[87]  R. Schachar,et al.  Parental Knowledge of Attention-Deficit Hyperactivity Disorder and Opinions of Treatment Options: Impact on Enrolment and Adherence to a 12-Month Treatment Trial , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[88]  A. Charach,et al.  Using stimulant medication for children with ADHD: what do parents say? A brief report. , 2006, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[89]  J. Swanson,et al.  Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[90]  L. Warner,et al.  Use of psychotropic medications by youths with psychiatric diagnoses in the U.S. mental health system. , 2004, Psychiatric services.

[91]  A. Krain,et al.  The Role of Treatment Acceptability in the Initiation of Treatment for ADHD , 2005, Journal of attention disorders.

[92]  M. Zimmer‐Gembeck,et al.  Depression as a longitudinal outcome and antecedent of preadolescents' peer relationships and peer-relevant cognition , 2009, Development and Psychopathology.

[93]  Vivian Kafantaris,et al.  Patterns of adherence to treatment in adolescents with bipolar disorder. , 2005, Journal of child and adolescent psychopharmacology.

[94]  J. Lieberman,et al.  A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial , 2004, Neuropsychopharmacology.

[95]  S. Stewart,et al.  Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[96]  R. Barkley,et al.  Does the treatment of attention‐deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? , 2003, Pediatrics.

[97]  B. Chow,et al.  Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. , 2001, Journal of child and adolescent psychopharmacology.

[98]  C. Conners.  Forty years of methylphenidate treatment in Attention-Deficit/Hyperactivity Disorder , 2002, Journal of attention disorders.

[99]  H. Feldman,et al.  Academic and educational outcomes of children with ADHD. , 2007, Journal of pediatric psychology.

[100]  J. Calabrese,et al.  Adherence to pharmacological treatment for juvenile bipolar disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[101]  P. M. Verbeek-Heida,et al.  Better safe than sorry — why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study , 2006, Chronic illness.

[102]  John J Dilallo,et al.  Motivational interviewing and adolescent psychopharmacology. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[103]  D. Pine,et al.  Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. , 2001, The New England journal of medicine.

[104]  R. Barkley,et al.  Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. , 1996, Pediatrics.

[105]  K. Boydell,et al.  A theoretical approach to medication adherence for children and youth with psychiatric disorders. , 2008, Harvard review of psychiatry.

[106]  D. Thiruchelvam,et al.  Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[107]  J. Barner,et al.  Assessment of Adherence Measures with Different Stimulants Among Children and Adolescents , 2005, Pharmacotherapy.

[108]  S. dosReis,et al.  African American Caretakers' Views of ADHD and Use of Outpatient Mental Health Care Services for Children , 2008 .

[109]  A. Carter,et al.  Parenting Stress in Mothers and Fathers of Toddlers with Autism Spectrum Disorders: Associations with Child Characteristics , 2008, Journal of autism and developmental disorders.

[110]  R. Barkley,et al.  Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. , 1993, Pediatrics.

[111]  J. Greenhouse,et al.  Rate and predictors of divorce among parents of youths with ADHD. , 2008, Journal of consulting and clinical psychology.

[112]  Churn-Shiouh Gau,et al.  Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. , 2006, Journal of child and adolescent psychopharmacology.

[113]  Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003. , 2005, MMWR. Morbidity and mortality weekly report.

[114]  Billy L. Smith,et al.  Stimulant medications: a trade-off? The lived experience of adolescents with ADHD. , 2006, Journal for specialists in pediatric nursing : JSPN.

[115]  J. Racoosin,et al.  Suicidality in pediatric patients treated with antidepressant drugs. , 2006, Archives of general psychiatry.

[116]  Vincent J Monastra,et al.  Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach. , 2005, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[117]  S. Faraone,et al.  An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS® Methylphenidate in Children With ADHD , 2007, Journal of attention disorders.